Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Shanghai - Delayed Quote CNY

Zhejiang Orient Gene Biotech Co., Ltd (688298.SS)

Compare
23.30
+0.07
+(0.30%)
At close: April 14 at 3:00:03 PM GMT+8
Currency in CNY All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
825,599.34
820,157.33
8,767,938.11
10,169,167.72
3,265,355.64
Cost of Revenue
486,896.92
467,402.66
4,314,399.06
2,665,324.82
677,777.58
Gross Profit
338,702.42
352,754.67
4,453,539.05
7,503,842.90
2,587,578.06
Operating Expense
855,797.26
780,973.80
1,332,355.79
1,621,546.76
463,269.63
Operating Income
-517,094.84
-428,219.13
3,121,183.26
5,882,296.13
2,124,308.43
Net Non Operating Interest Income Expense
-17,775.75
188,412.92
106,251.82
32,481.51
2,622.23
Pretax Income
-635,673.74
-404,226.73
2,470,752.36
5,769,965.57
1,974,281.46
Tax Provision
-10,443.72
14,042.10
373,321.13
829,319.80
293,950.24
Net Income Common Stockholders
-587,355.87
-397,583.60
2,067,714.33
4,920,188.15
1,677,358.74
Basic EPS
-2.93
-1.97
12.31
34.17
8.50
Diluted EPS
-2.93
-1.97
12.31
34.17
8.50
Basic Average Shares
199,971.54
201,819.08
167,970.30
144,005.51
197,336.32
Diluted Average Shares
199,971.54
201,819.08
167,970.30
144,005.51
197,336.32
Total Operating Income as Reported
-621,943.06
-383,834.66
2,528,210.10
5,776,398.89
1,974,346.17
Rent Expense Supplemental
--
--
--
--
3,091.28
Total Expenses
1,342,694.17
1,248,376.46
5,646,754.85
4,286,871.58
1,141,047.21
Net Income from Continuing & Discontinued Operation
-587,355.87
-397,583.60
2,067,714.33
4,920,188.15
1,677,358.74
Normalized Income
-350,512.05
-204,547.83
3,088,345.04
4,962,815.34
1,768,581.04
Interest Income
133,106.50
207,669.15
116,842.99
34,868.85
4,947.71
Interest Expense
20,725.62
18,120.03
6,966.96
936.30
44.61
Net Interest Income
-17,775.75
188,412.92
106,251.82
32,481.51
2,622.23
EBIT
-614,948.12
-386,106.70
2,477,719.33
5,770,901.86
1,974,326.07
EBITDA
-614,948.12
-220,617.45
2,564,278.95
5,808,207.70
1,981,765.27
Reconciled Cost of Revenue
486,896.92
467,402.66
4,314,399.06
2,665,324.82
677,777.58
Reconciled Depreciation
--
165,489.25
86,559.62
37,305.84
7,439.20
Net Income from Continuing Operation Net Minority Interest
-587,355.87
-397,583.60
2,067,714.33
4,920,188.15
1,677,358.74
Total Unusual Items Excluding Goodwill
-240,800.01
-257,381.02
-1,202,292.45
-49,782.45
-107,180.35
Total Unusual Items
-240,800.01
-257,381.02
-1,202,292.45
-49,782.45
-107,180.35
Normalized EBITDA
-374,148.11
36,763.56
3,766,571.40
5,857,990.15
2,088,945.62
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-3,956.19
-64,345.25
-181,661.74
-7,155.25
-15,958.05
12/31/2020 - 2/5/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade
Waiting for permission
Allow microphone access to enable voice search

Try again.